Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Medicine for Pregnant Women: Novel Metabolomic and Proteomic Biomarkers to Detect Pre-eclampsia and Improve Outcome.

NCT01891240 is registered in ClinicalTrials.gov with Louise Kenny as lead sponsor.

NCT NCT01891240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01891240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Medicine for Pregnant Women: Novel Metabolomic and Proteomic Biomarkers to Detect Pre-eclampsia and Improve Outcome.
Lead sponsor
Louise Kenny
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2013
Completion date
April 30, 2018
Enrollment
5,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pre-eclampsia, pregnancy, pregnancy complications, pregnancy, high-risk